Decreased intercellular communication and connexin expression in mouse aortic endothelium during lipopolysaccharide-induced inflammation

Journal of Vascular Research

Volumn 41, Issue 4, 2004, Pages 323-333

  Simon, Alexander M ^a,c   McWhorter, Andrea R ^a   Chen, HwuDauRw ^a   Jackson, Charity L ^a   Ouellette, Yves ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aorta; Connexin37; Connexin40; Endothelium; Endotoxin; Gap junction; Intercellular communication; Lipopolysaccharide; Sepsis

Indexed keywords

CONNEXIN 37; CONNEXIN 40; DYE; GAP JUNCTION PROTEIN; LIPOPOLYSACCHARIDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; INFLAMMATION; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; AORTA; AORTITIS; CELL COMMUNICATION; CELL COUNT; CONNEXINS; ENDOTHELIUM, VASCULAR; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; LYSINE; MICE; MICE, KNOCKOUT;

EID: 5644239564     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079614     Document Type: Article

References (61)

1. Segal SS, Duling BR: Conduction of vasomotor responses in arterioles: A role for cell-to-cell coupling? Am J Physiol 1989;256:H838-H845.
2. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U: Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000;86:649-655.
3. Figueroa XF, Paul DL, Simon AM, Goodenough DA, Day KH, Damon DN, Duling BR: Central role of connexin40 in the propagation of electrically activated vasodilation in mouse cremasteric arterioles in vivo. Circ Res 2003;92:793-800.
4. Chaytor AT, Evans WH, Griffith TM: Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol 1998;508:561-573.
5. Harris AL: Emerging issues of connexin channels: Biophysics fills the gap. Q Rev Biophys 2001;34:325-472.
6. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G: Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725-737.
7. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC: Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 2003;83:1359-1400.
8. Bruzzone R, Haefliger JA, Gimlich RL, Paul DL: Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. Mol Biol Cell 1993;4:7-20.
9. Gabriels JE, Paul DL: Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998;83:636-643.
10. Larson DM, Haudenschild CC, Beyer EC: Gap junction messenger RNA expression by vascular wall cells. Circ Res 1990;66:1074-1080.
11. Little TL, Beyer EC, Duling BR: Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am J Physiol 1995;268:H729-H739.
12. Reed KE, Westphale EM, Larson DM, Wang H-Z, Veenstra RD, Beyer EC: Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest 1993;91:997-1004.
13. Traub O, Hertlein B, Kasper M, Eckert R, Krisciukaitis A, Hulser D, Willecke K: Characterization of the gap junction protein connexin37 in murine endothelium, respiratory epithelium, and after transfection in human HeLa cells. Eur J Cell Biol 1998;77:313-322.
14. van Kempen MJ, Jongsma HJ: Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999;112:479-486.
15. Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ: Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res 1998;83:1248-1263.
16. Krüger O, Beny JL, Chabaud F, Traub O, Theis M, Brix K, Kirchhoff S, Willecke K: Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res 2002;39:160-172.
17. Simon AM, McWhorter AR: Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci 2003;116:2223-2236.
18. Alexander C, Rietschel ET: Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001;7:167-202.
19. Henneke P, Golenbock DT: Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002;30:S207-S213.
20. Raetz CR, Whitfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
21. Bannerman DD, Goldblum SE: Mechanisms of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L899-L914.
22. Levi M, ten Cate H, van der Poll T, van Deventer SJ: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993;270:975-979.
23. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-233.
24. Bannerman DD, Goldblum SE: Direct effects of endotoxin on the endothelium: Barrier function and injury. Lab Invest 1999;79:1181-1199.
25. Bannerman DD, Fitzpatrick MJ, Anderson DY, Bhattacharjee AK, Novitsky TJ, Hasday JD, Cross AS, Goldblum SE: Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect Immun 1998;66:1400-1407.
26. Martin MA, Silverman HJ: Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 1992;14:1213-1228.
27. Volk T, Kox WJ: Endothelium function in sepsis. Inflamm Res 2000;49:185-198.
28. Hinshaw LB: Sepsis/septic shock: Participation of the microcirculation: An abbreviated review. Crit Care Med 1996;24:1072-1078.
29. Lidington D, Tyml K, Ouellette Y: Lipopolysaccharide-induced reductions in cellular coupling correlate with tyrosine phosphorylation of connexin 43. J Cell Physiol 2002;193:373-379.
30. Lidington D, Ouellette Y, Tyml K: Endotoxin increases intercellular resistance in microvascular endothelial cells by a tyrosine kinase pathway. J Cell Physiol 2000;185:117-125.
31. Tyml K, Wang X, Lidington D, Ouellette Y: Lipopolysaccharide reduces intercellular coupling in vitro and arteriolar conducted response in vivo. Am J Physiol Heart Circ Physiol 2001;281:H1397-H1406.
32. Lidington D, Ouellette Y, Li F, Tyml K: Conducted vasoconstriction is reduced in a mouse model of sepsis. J Vasc Res 2003;40:149-158.
33. Hu VW, Xie HQ: Interleukin-1-alpha suppresses gap junction-mediated intercellular communication in human endothelial cells. Exp Cell Res 1994;213:218-223.
34. Hu J, Cotgreave IA: Differential regulation of gap junctions by proinflammatory mediators in vitro. J Clin Invest 1997;99:2312-2316.
35. van Rijen HVM, van Kempen MJA, Postma S, Jongsma HJ: Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 1998;10:258-264.
36. Simon AM, Goodenough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 1997;385:525-529.
37. Simon AM, Goodenough DA, Paul DL: Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998;8:295-298.
38. Simon AM, McWhorter AR: Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 2002;251:206-220.
39. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP: Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 1995;270:16395-16401.
40. Loo LW, Berestecky JM, Kanemitsu MY, Lau AF: pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J Biol Chem 1995;270:12751-12761.
41. Hertzberg EL: A detergent-independent procedure for the isolation of gap junctions from rat liver. J Biol Chem 1984;259:9936-9943.
42. Koval M, Geist ST, Westphale EM, Kemendy AE, Civitelli R, Beyer EC, Steinberg TH: Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43. J Cell Biol 1995;130:987-995.
43. Schubert AL, Schubert W, Spray DC, Lisanti MP: Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002;41:5754-5764.
44. Grisham MB, Everse J, Janssen HF: Endotoxemia and neutrophil activation in vivo. Am J Physiol 1988;254:H1017-H1022.
45. Triantafilou M, Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23:301-304.
46. Heine H, Lien E: Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003;130:180-192.
47. Zhang G, Ghosh S: Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 2000;6:453-457.
48. Diks SH, van Deventer SJ, Peppelenbosch MP: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects. J Endotoxin Res 2001;7:335-348.
49. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M, Arditi M: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000;275:11058-11063.
50. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-10692.
51. Lidington D, Ouellette Y, Tyml K: Communication of agonist-induced electrical responses along 'capillaries' in vitro can be modulated by lipopolysaccharide, but not nitric oxide. J Vasc Res 2002;39:405-413.
52. Gingalewski C, Wang K, Clemens MG, De Maio A: Posttranscriptional regulation of connexin 32 expression in liver during acute inflammation. J Cell Physiol 1996;166:461-467.
53. Jara PI, Boric MP, Saez JC: Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc Natl Acad Sci USA 1995;92:7011-7015.
54. Gingalewski C, De Maio A: Differential decrease in connexin 32 expression in ischemic and nonischemic regions of rat liver during ischemia/reperfusion. J Cell Physiol 1997;171:20-27.
55. Temme A, Ott T, Haberberger T, Traub O, Willecke K: Acute-phase response and circadian expression of connexin26 are not altered in connexin32-deficient mouse liver. Cell Tissue Res 2000;300:111-117.
56. Green CR, Severs NJ: Robert Feulgen Prize Lecture. Distribution and role of gap junctions in normal myocardium and human ischaemic heart disease. Histochemistry 1993;99:105-120.
57. Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A: Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999;11:216-224.
58. Fernandez-Cobo M, Gingalewski C, De Maio A: Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock 1998;10:97-102.
59. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF: IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 1999;96:11613-11618.
60. 2+-dependent mechanism. Biorheology 2002;39:153-160.
61. Branes MC, Contreras JE, Saez JC: Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit 2002;8:BR313-BR323.